Literature DB >> 32565744

Dosimetric comparison of dynamic conformal arc integrated with segment shape optimization and variable dose rate versus volumetric modulated arc therapy for liver SBRT.

Deepak Thaper1,2, Rose Kamal1,2, Gaganpreet Singh1,3, Arun S Oinam3, Hanuman P Yadav2, Rishabh Kumar2, Vivek Kumar1.   

Abstract

PURPOSE: The aim is a dosimetric comparison of dynamic conformal arc integrated with the segment shape optimization and variable dose rate (DCA_SSO_VDR) versus VMAT for liver SBRT and interaction of various treatment plan quality indices with PTV and degree of modulation (DoM) for both techniques. MATERIAL: Twenty-five patients of liver SBRT treated using the VMAT technique were selected. DCA_SSO_VDR treatment plans were also generated for all patients in Monaco TPS using the same objective constraint template and treatment planning parameters as used for the VMAT technique. For comparison purpose, organs at risk (OARs) doses and treatment plans quality indices, such as maximum dose of PTV (Dmax%), mean dose of PTV (Dmean%), maximum dose at 2 cm in any direction from the PTV (D2cm%), total monitor units (MU's), gradient index R50%, degree of modulation (DoM), conformity index (CI), homogeneity index (HI), and healthy tissue mean dose (HTMD), were compared.
RESULTS: Significant dosimetric differences were observed in several OARs doses and lowered in VMAT plans. The D2cm%, R50%, CI, HI and HTMD are dosimetrically inferior in DCA_SSO_VDR plans. The higher DoM results in poor dose gradient and better dose gradient for DCA_SSO_VDR and VMAT treatment plans, respectively.
CONCLUSIONS: For liver SBRT, DCA_SSO_VDR treatment plans are neither dosimetrically superior nor better alternative to the VMAT delivery technique. A reduction of 69.75% MU was observed in DCA_SSO_VDR treatment plans. For the large size of PTV and high DoM, DCA_SSO_VDR treatment plans result in poorer quality.
© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DCA; Dosimetric; SBRT; SSO; VDR; VMAT

Year:  2020        PMID: 32565744      PMCID: PMC7298676          DOI: 10.1016/j.rpor.2020.04.017

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  26 in total

1.  A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note.

Authors:  I Paddick
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

2.  Stereotactic body radiation therapy: the report of AAPM Task Group 101.

Authors:  Stanley H Benedict; Kamil M Yenice; David Followill; James M Galvin; William Hinson; Brian Kavanagh; Paul Keall; Michael Lovelock; Sanford Meeks; Lech Papiez; Thomas Purdie; Ramaswamy Sadagopan; Michael C Schell; Bill Salter; David J Schlesinger; Almon S Shiu; Timothy Solberg; Danny Y Song; Volker Stieber; Robert Timmerman; Wolfgang A Tomé; Dirk Verellen; Lu Wang; Fang-Fang Yin
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

3.  Technical and dosimetric aspects of respiratory gating using a pressure-sensor motion monitoring system.

Authors:  X Allen Li; Christopher Stepaniak; Elizabeth Gore
Journal:  Med Phys       Date:  2006-01       Impact factor: 4.071

4.  Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.

Authors:  Quentin Diot; Brian Kavanagh; Tracey Schefter; Laurie Gaspar; Kelly Stuhr; Moyed Miften
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-12       Impact factor: 7.038

5.  Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.

Authors:  Laura Masi; Raffaela Doro; Virginia Favuzza; Samantha Cipressi; Lorenzo Livi
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

6.  Influence of monte carlo variance with fluence smoothing in VMAT treatment planning with Monaco TPS.

Authors:  B Sarkar; A Manikandan; M Nandy; A Munshi; P Sayan; N Sujatha
Journal:  Indian J Cancer       Date:  2016 Jan-Mar       Impact factor: 1.224

7.  Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs.

Authors:  Wilko F A R Verbakel; Suresh Senan; Johan P Cuijpers; Ben J Slotman; Frank J Lagerwaard
Journal:  Radiother Oncol       Date:  2009-06-22       Impact factor: 6.280

8.  Retrospective assessment of a single fiducial marker tracking regimen with robotic stereotactic body radiation therapy for liver tumours.

Authors:  Masao Nakayama; Kazuyuki Uehara; Hideki Nishimura; Shuhei Tamura; Yoshiki Munetomo; Shinji Tsudou; Hiroshi Mayahara; Naritoshi Mukumoto; Moshi Geso; Ryohei Sasaki
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-21

9.  Comparison of volumetric-modulated arc therapy and dynamic conformal arc treatment planning for cranial stereotactic radiosurgery.

Authors:  Jessica Molinier; Christine Kerr; Sebastien Simeon; Norbert Ailleres; Marie Charissoux; David Azria; Pascal Fenoglietto
Journal:  J Appl Clin Med Phys       Date:  2016-01-08       Impact factor: 2.102

10.  Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer.

Authors:  Kazuki Kubo; Hajime Monzen; Mikoto Tamura; Makoto Hirata; Kentaro Ishii; Wataru Okada; Ryuta Nakahara; Shun Kishimoto; Ryu Kawamorita; Yasumasa Nishimura
Journal:  J Appl Clin Med Phys       Date:  2018-01-25       Impact factor: 2.102

View more
  2 in total

1.  Efficacy and toxicity of SBRT in advanced hepatocellular carcinoma with portal vein tumor thrombosis - a retrospective study.

Authors:  Rishabh Kumar; Hanuman Prasad Yadav; Deepak Thaper; Rose Kamal; Anil Gupta; S Kirti
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

2.  Dosimetric impact of contrast-enhanced 4d computed tomography for stereotactic body radiation therapy of hepatocelluar carcinoma.

Authors:  Rose Kamal; Deepak Thaper; Rishabh Kumar; Gaganpreet Singh; Hanuman P Yadav; Arun S Oinam; Vivek Kumar; Hitesh Sharma
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.